Survey on the Treatment of Hypertension in Patients With Type 2 Diabetes

AstraZeneca

Status: Completed

Conditions: Hypertension; Type 2 Diabetes

Study type: Observational

Funder types: Industry

Identifiers

NCT00803660

NIS-CVN-DUM-2008/1

Details and patient eligibility

About

Multi-centre survey of type 2 diabetic patients who are currently on anti-hypertensive treatment. Data collection for each patient will take place at one visit. To observe the proportion of diabetic patients on antihypertensive treatment reaching the BP<130/80 mmHg. To observe the proportion of diabetic patients on antihypertensive treatment reaching the BP<130/80 mmHg by treatment groups. To observe the proportion of patients achieving a therapeutic glycemic response defined as HbA1c=<7%. To observe the proportion of patients achieving fasting plasma glucose<110 mg%. To identify factors for not achieving BP<130/80 mmHg. To describe percentage of patients with positive proteinuria (including microalbuminuria) by treatment groups .

Enrollment: 1,060 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Provision of written informed consent
• Patient was diagnosed with type 2 diabetes
• Patient is on antihypertensive treatments for at least 3 months, with the same regimen for a minimum of 4 weeks prior to survey

Exclusion criteria

• Patients are critically ill, had mental health problems or difficulty in communication
• Patients who are unwilling or unable to provide informed consent
• Involvement in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site).